Skip to main content Back to Top
Advertisement

9/22/2021

Pantoprazole Injection

Products Affected - Description

    • Protonix IV, Pfizer, 40 mg, vial, 25 count, NDC 00008-0923-60
    • Pantoprazole lyophilized powder for injection, Hikma, 40 mg, vial, 10 count, NDC 00143-9284-10
    • Pantoprazole powder for solution for injection, Sun Pharma, 40 mg, vial, 10 count, NDC 62756-0129-44

Reason for the Shortage

    • AuroMedics had pantoprazole injection on shortage due to increased demand.
    • Fresenius Kabi has pantoprazole injection available.
    • Hikma has pantoprazole injection on shortage due to increased demand.
    • Pfizer has Protonix injection on shortage due to increased demand.
    • Sandoz had pantoprazole injection on shortage due to increased demand.
    • Sun Pharma has recently resumed manufacturing of pantoprazole injection.

Available Products

    • Protonix IV, Pfizer, 40 mg, vial, 10 count, NDC 00008-0923-55
    • Pantoprazole lyophilized powder for solution for injection, AuroMedics, 40 mg, vial, 10 count, NDC 55150-0202-10
    • Pantoprazole lyophilized powder for injection, Fresenius Kabi, 40 mg, vial, 10 count, NDC 65219-0433-15
    • Pantoprazole lyophilized powder for injection, Sandoz, 40 mg, vial, 10 count, NDC 00781-3232-95

Estimated Resupply Dates

    • Hikma has pantoprazole 40 mg vials on allocation.
    • Pfizer has Protonix 40 mg vials in 25 count on back order and the company estimates a release date in September 2021.
    • Sun Pharma has pantoprazole 40 mg vials on back order and the company estimates a release date in 4th quarter 2021.

Updated

Updated September 22, 2021 by Leslie Jensen, PharmD, Drug Information Specialist. Created March 28, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.